311 related articles for article (PubMed ID: 21868365)
41. Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop.
Stiehl DP; Bordoli MR; Abreu-Rodríguez I; Wollenick K; Schraml P; Gradin K; Poellinger L; Kristiansen G; Wenger RH
Oncogene; 2012 May; 31(18):2283-97. PubMed ID: 21927022
[TBL] [Abstract][Full Text] [Related]
42. Pro-neoplastic effects of amphiregulin in colorectal carcinogenesis.
Guzman MJ; Shao J; Sheng H
J Gastrointest Cancer; 2013 Jun; 44(2):211-21. PubMed ID: 23263765
[TBL] [Abstract][Full Text] [Related]
43. Human oocyte maturation is dependent on LH-stimulated accumulation of the epidermal growth factor-like growth factor, amphiregulin.
Zamah AM; Hsieh M; Chen J; Vigne JL; Rosen MP; Cedars MI; Conti M
Hum Reprod; 2010 Oct; 25(10):2569-78. PubMed ID: 20719813
[TBL] [Abstract][Full Text] [Related]
44. Activation of the epidermal growth factor receptor promotes lymphangiogenesis in the skin.
Marino D; Angehrn Y; Klein S; Riccardi S; Baenziger-Tobler N; Otto VI; Pittelkow M; Detmar M
J Dermatol Sci; 2013 Sep; 71(3):184-94. PubMed ID: 23706492
[TBL] [Abstract][Full Text] [Related]
45. The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.
Sørensen BS; Tørring N; Bor MV; Nexø E
Mol Cell Biochem; 2004 May; 260(1-2):129-35. PubMed ID: 15228094
[TBL] [Abstract][Full Text] [Related]
46. Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells.
Accornero P; Miretti S; Bersani F; Quaglino E; Martignani E; Baratta M
PLoS One; 2012; 7(9):e44982. PubMed ID: 23028720
[TBL] [Abstract][Full Text] [Related]
47. Bronchial epithelial compression regulates epidermal growth factor receptor family ligand expression in an autocrine manner.
Chu EK; Foley JS; Cheng J; Patel AS; Drazen JM; Tschumperlin DJ
Am J Respir Cell Mol Biol; 2005 May; 32(5):373-80. PubMed ID: 15705969
[TBL] [Abstract][Full Text] [Related]
48. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.
Khambata-Ford S; Garrett CR; Meropol NJ; Basik M; Harbison CT; Wu S; Wong TW; Huang X; Takimoto CH; Godwin AK; Tan BR; Krishnamurthi SS; Burris HA; Poplin EA; Hidalgo M; Baselga J; Clark EA; Mauro DJ
J Clin Oncol; 2007 Aug; 25(22):3230-7. PubMed ID: 17664471
[TBL] [Abstract][Full Text] [Related]
49. Cyclin D1 determines estrogen signaling in the mammary gland in vivo.
Casimiro MC; Wang C; Li Z; Di Sante G; Willmart NE; Addya S; Chen L; Liu Y; Lisanti MP; Pestell RG
Mol Endocrinol; 2013 Sep; 27(9):1415-28. PubMed ID: 23864650
[TBL] [Abstract][Full Text] [Related]
50. Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer.
Baillo A; Giroux C; Ethier SP
J Cell Physiol; 2011 Oct; 226(10):2691-701. PubMed ID: 21302279
[TBL] [Abstract][Full Text] [Related]
51. EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy.
Liu S; Wang Y; Han Y; Xia W; Zhang L; Xu S; Ju H; Zhang X; Ren G; Liu L; Ye W; Zhang Z; Hu J
Theranostics; 2020; 10(23):10589-10605. PubMed ID: 32929368
[No Abstract] [Full Text] [Related]
52. Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop.
Willmarth NE; Baillo A; Dziubinski ML; Wilson K; Riese DJ; Ethier SP
Cell Signal; 2009 Feb; 21(2):212-9. PubMed ID: 18951974
[TBL] [Abstract][Full Text] [Related]
53. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.
el-Marjou A; Delouvée A; Thiery JP; Radvanyi F
Carcinogenesis; 2000 Dec; 21(12):2211-8. PubMed ID: 11133810
[TBL] [Abstract][Full Text] [Related]
54. Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate.
Adam RM; Borer JG; Williams J; Eastham JA; Loughlin KR; Freeman MR
Endocrinology; 1999 Dec; 140(12):5866-75. PubMed ID: 10579352
[TBL] [Abstract][Full Text] [Related]
55. Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival.
Farooqui M; Bohrer LR; Brady NJ; Chuntova P; Kemp SE; Wardwell CT; Nelson AC; Schwertfeger KL
Mol Cancer; 2015 Jul; 14():138. PubMed ID: 26215578
[TBL] [Abstract][Full Text] [Related]
56. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.
Berquin IM; Dziubinski ML; Nolan GP; Ethier SP
Oncogene; 2001 Jul; 20(30):4019-28. PubMed ID: 11494130
[TBL] [Abstract][Full Text] [Related]
57. Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis.
Reed JR; Leon RP; Hall MK; Schwertfeger KL
Breast Cancer Res; 2009; 11(2):R21. PubMed ID: 19393083
[TBL] [Abstract][Full Text] [Related]
58. Amphiregulin as a novel target for breast cancer therapy.
Willmarth NE; Ethier SP
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):171-9. PubMed ID: 18437539
[TBL] [Abstract][Full Text] [Related]
59. Metalloproteinase-mediated, context-dependent function of amphiregulin and HB-EGF in human keratinocytes and skin.
Stoll SW; Johnson JL; Bhasin A; Johnston A; Gudjonsson JE; Rittié L; Elder JT
J Invest Dermatol; 2010 Jan; 130(1):295-304. PubMed ID: 19609315
[TBL] [Abstract][Full Text] [Related]
60. EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix.
Zhu J; Shimizu E; Zhang X; Partridge NC; Qin L
J Cell Biochem; 2011 Jul; 112(7):1749-60. PubMed ID: 21381079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
